PCRX Pacira BioSciences, Inc.
Last updated: Nov 16, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 2/4 quarters. Q3 2026: $50M, Q2 2026: $50M, Q1 2026: $0M, Q3 2025: $0M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $50M vs trailing avg $17M (+200%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.
Negative FCF ($-149M), buybacks not supported by cash flow
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 9,258,452 shares = 22.5% of 41,116,739 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
No insider open-market purchases in the last 12 months
Insider-Buyback Convergence
Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.
Need both buyback and insider purchase data
Insider Net Direction
Over the last 90 days, are insiders net buyers or net sellers on the open market?
Insiders bought $0M, sold $0M in the last 90 days (net selling)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
Company buying back stock while insiders sold 2483638.9x more than bought. 4 C-suite officers among sellers
- RIKER LAUREN (Senior Vice President, Finance) sold 6,000 shares on 2026-10-08
- SLONIN JONATHAN (Chief Medical Officer) sold 3,040 shares on 2026-08-17
- RIKER LAUREN (Senior Vice President, Finance) sold 6,115 shares on 2026-06-11
- WILLIAMS KRISTEN (Chief Administrative Officer) sold 10,259 shares on 2026-06-04
- Cross Shawn (Chief Financial Officer) sold 12,941 shares on 2026-04-23
- Cross Shawn (Chief Financial Officer) sold 7,714 shares on 2026-04-20
- Cross Shawn (Chief Financial Officer) sold 2,845 shares on 2026-04-21
- Cross Shawn (Chief Financial Officer) sold 1,500 shares on 2026-04-22
- SLONIN JONATHAN (Chief Medical Officer) sold 3,261 shares on 2026-03-17
- RIKER LAUREN (Senior Vice President, Finance) sold 4,000 shares on 2026-02-02